![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 11, 2013 8:28:39 PM
Not sure about what you wrote. Why would they advertise it in their pipeline...? They aren't as far as what I've seen, they only state QS M (neurology). And we won't know what it is until they get this out of preclinical and into the clinical trials.
Also for a clarification is anyone saw my post on ymb (3rd post in a series) when I mentioned the PFE / Antares clinical trial. It looks like very soon after I reviewed the trial for the 5% gel and the latest date of August, they updated the trial date to September. But importantly, they are still in the "enrollment" phase. I expect another payment from Pfizer when enrollment is completed or at least I hope that is the case.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM